Home Search Search Results for: ” page/3” 2023 Savings Report U.S. Generic and Biosimilar Medicines Savings Report Generics and biosimilar medicines deliver more savings every year. At a moment when policymakers are contemplating measures to reduce drug prices for American patients, AAM’s 2023 U.S. Generic and Biosimilar Medicines Savings Report, featuring data from IQVIA, […]
Originally published on the Biosimilars Council. Biosimilar medicines are revolutionary therapeutics that treat patients at a fraction of the cost of brand-name biologics. However, public awareness and trust of biosimilars is still evolving, meaning many patients and providers are overpaying for expensive brand-name biologics. To address this education gap, the Biosimilars Council launched a new, […]
According to the latest U.S. Generic and Biosimilar Medicines Savings Report, Americans who took generics and biosimilars saved $338 billion in health care costs in 2020 and nearly $2.4 trillion in the last decade. These medicines provide budgetary relief throughout the U.S. health care system, and taxpayers in all 50 states benefit from the savings […]
I joined AAM just over one year ago, and one of the first things that I did was a media tour of over 25 markets around the country to talk about the incredible data contained in our 2020 annual savings report. For someone like me who spent many years working on the brand side of […]
At AAM, we measure our impact by the lives we affect. And to do that, we have a strong team working hard every day for patient access to FDA-approved, affordable, effective generics and biosimilars. In the last few months, additional professionals have joined our team. I’m proud to serve as Chief Operating Officer, and we have […]
Generic Drug and Biosimilars Access and Savings in the U.S. Every year, the Association for Accessible Medicines (AAM) releases a report documenting the billions of dollars that the U.S. health care system saves through generic and biosimilar prescription medicines. Here are some highlights from the 2020 report: America’s patients and our health care system saved $313 […]
The coronavirus pandemic has affected all of us. One health-related concern that has not gotten a lot of media attention is patients’ ability to obtain their prescription medications. The Association for Accessible Medicines recognizes that medicines don’t work if the patient can’t take them. FAQs: How Is the Generic Pharmaceutical Industry Responding? We’re inviting YOU […]
Nine months ago—don’t make too much of the time period—a team at AAM formed Women in Health Policy (WiHP), a supportive network geared toward two goals: increasing the number of women guiding our nation’s health care amplifying their effectiveness and professional advancement The response has been gratifying, and our LinkedIn group already counts 500 members. […]
Members of the Association for Accessible Medicines form an integral and powerful part of the health care system. When companies join AAM, they commit to honoring a code of business ethics. In addition, many of them run robust corporate social responsibility (CSR) programs, benefiting their immediate communities and patients around the world. Here is a […]
Home Search Search Results for: ” page/3” Overview To view the latest data, view 2020 Access & Savings Report 2019 Generic Drug and Biosimilars Access and Savings in the U.S. The 11th annual edition of AAM’s Savings and Access Report quantifies how much money American patients and our health care system are saving because […]
“You’re definitely going to hear more about women in health policy this year.” This prediction from Nancy Snyderman, formerly NBC Chief Medical Officer, at Access! 2019, was fulfilled immediately as four health care executives launched into an energetic panel discussion on how they embody leadership in the boardroom and the home and shifting currents in […]
The FDA’s Office of Pharmaceutical Quality (OPQ) describes its mission as “the closer integration of review, inspection, surveillance, policy, and research for the purpose of strengthening pharmaceutical quality on a global scale,” with a motto of “One Quality Voice.” Every year, our Chemistry, Manufacturing & Controls (CMC) workshop helps participants to stay on top of the latest […]
